Pharma Execs Face Murder Charges
The U.S. attorney’s office has charged Barry Cadden, owner of New England Compounding Center and Glenn Chin, head pharmacist, with 25 acts of second-degree murder in seven states.
EU Bans Imports of Ranbaxy Injectables
The European Union has banned imports from the Ranbaxy Laboratories' Dewas plant, which manufactures injectable antibotics, after the unit failed an inspection.
Hospira Warned by FDA, Again
USA-based injectable drug manufacturer Hospira has disclosed in a U.S. Securities and Exchange Commission filing that the company had received a warning letter from the U.S. FDA following an inspection of the company’s manufacturing facility in Victoria, Australia.